EI
EnZeta Immunotherapies, Inc.
SEC filingBiotechnology · Coral Gables, FL
Amount raised$840Ksold at filing
Total offering$2.4M$1.5M still open
Investors in the raise10count reported to the SEC
FiledMar 6, 2026first sale Feb 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul KellyExecutive Officer, Director
Sergio TraversaDirector
Executive officers, directors and promoters as listed on the Form D.